Literature DB >> 32512028

Three significant highlights of controlled drug delivery over the past 55 years: PEGylation, ADCs, and EPR.

Allan S Hoffman1, James J Lai2.   

Abstract

Year:  2020        PMID： 32512028     DOI： 10.1016/j.addr.2020.05.013

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  5 in total

Review 1.  New Perspective on Natural Plant Protein-Based Nanocarriers for Bioactive Ingredients Delivery.

Authors:  Chaoting Wen; Jixian Zhang; Haihui Zhang; Yuqing Duan
Journal:  Foods       Date:  2022-06-09

2.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

Review 3.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

Review 4.  Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy.

Authors:  Xiaowei Wang; Yuhan Qiu; Mengyan Wang; Conghui Zhang; Tianshu Zhang; Huimin Zhou; Wenxia Zhao; Wuli Zhao; Guimin Xia; Rongguang Shao
Journal:  Int J Nanomedicine       Date:  2020-11-25

Review 5.  Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer.

Authors:  Xu Lin; Jiahe Wu; Yupeng Liu; Nengming Lin; Jian Hu; Bo Zhang
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.